Trial NCT02200562

View at ClinicalTrials.gov 
Org. Study IDs: HCI68132

Last trial update was posted on 2017-03-01

MeSH Interventions

Dabrafenib Ipilimumab

MeSH Conditions

Melanoma

Other Conditions

Stage III or IV Melanoma

Stopping Reasons

BMS withdrew support and required this trial to stop enrolling; Phase II portion never began, only a Phase I trial.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID